Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs BETA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GODAVARI DRU BETA DRUGS GODAVARI DRU/
BETA DRUGS
 
P/E (TTM) x 13.2 - - View Chart
P/BV x 2.2 12.1 18.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GODAVARI DRU   BETA DRUGS
EQUITY SHARE DATA
    GODAVARI DRU
Mar-24
BETA DRUGS
Mar-24
GODAVARI DRU/
BETA DRUGS
5-Yr Chart
Click to enlarge
High Rs1141,595 7.1%   
Low Rs73645 11.4%   
Sales per share (Unadj.) Rs208.1307.7 67.6%  
Earnings per share (Unadj.) Rs7.437.9 19.4%  
Cash flow per share (Unadj.) Rs10.048.1 20.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs51.7163.5 31.7%  
Shares outstanding (eoy) m7.539.61 78.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.53.6 12.4%   
Avg P/E ratio x12.729.5 43.0%  
P/CF ratio (eoy) x9.323.3 40.1%  
Price / Book Value ratio x1.86.9 26.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m70510,765 6.6%   
No. of employees `000NANA-   
Total wages/salary Rs m51201 25.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,5672,957 53.0%  
Other income Rs m614 42.8%   
Total revenues Rs m1,5732,972 52.9%   
Gross profit Rs m132599 22.1%  
Depreciation Rs m2098 20.4%   
Interest Rs m4928 174.3%   
Profit before tax Rs m69488 14.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m14123 11.1%   
Profit after tax Rs m55364 15.2%  
Gross profit margin %8.420.3 41.6%  
Effective tax rate %19.825.3 78.5%   
Net profit margin %3.512.3 28.7%  
BALANCE SHEET DATA
Current assets Rs m8851,876 47.2%   
Current liabilities Rs m820944 86.9%   
Net working cap to sales %4.131.5 13.1%  
Current ratio x1.12.0 54.3%  
Inventory Days Days313 23.4%  
Debtors Days Days1,384978 141.5%  
Net fixed assets Rs m463748 61.8%   
Share capital Rs m7596 78.3%   
"Free" reserves Rs m3141,475 21.3%   
Net worth Rs m3901,571 24.8%   
Long term debt Rs m11260 184.9%   
Total assets Rs m1,3482,624 51.4%  
Interest coverage x2.418.3 13.2%   
Debt to equity ratio x0.30 745.4%  
Sales to assets ratio x1.21.1 103.2%   
Return on assets %7.815.0 51.9%  
Return on equity %14.223.2 61.4%  
Return on capital %23.631.6 74.7%  
Exports to sales %1.515.0 10.2%   
Imports to sales %58.90.4 16,749.7%   
Exports (fob) Rs m24445 5.4%   
Imports (cif) Rs m92310 8,879.6%   
Fx inflow Rs m24445 5.4%   
Fx outflow Rs m92741 2,252.7%   
Net fx Rs m-902404 -223.5%   
CASH FLOW
From Operations Rs m184309 59.5%  
From Investments Rs m-132-140 94.6%  
From Financial Activity Rs m-57-75 75.5%  
Net Cashflow Rs m-595 -4.9%  

Share Holding

Indian Promoters % 52.6 66.7 78.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.5 1.3 38.5%  
FIIs % 0.0 1.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 47.4 33.3 142.4%  
Shareholders   7,709 2,567 300.3%  
Pledged promoter(s) holding % 0.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GODAVARI DRU With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GODAVARI DRU vs BETA DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GODAVARI DRU vs BETA DRUGS Share Price Performance

Period GODAVARI DRU BETA DRUGS S&P BSE HEALTHCARE
1-Day 1.85% 0.00% 0.78%
1-Month -4.54% 0.00% -0.69%
1-Year 18.47% 0.00% 42.97%
3-Year CAGR 27.18% 0.00% 20.17%
5-Year CAGR 50.95% 0.00% 26.13%

* Compound Annual Growth Rate

Here are more details on the GODAVARI DRU share price and the BETA DRUGS share price.

Moving on to shareholding structures...

The promoters of GODAVARI DRU hold a 52.6% stake in the company. In case of BETA DRUGS the stake stands at 66.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GODAVARI DRU and the shareholding pattern of BETA DRUGS .

Finally, a word on dividends...

In the most recent financial year, GODAVARI DRU paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BETA DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of GODAVARI DRU, and the dividend history of BETA DRUGS .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.